Haibin Liang
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 4
- Toxicology top 10%
-
- RNA modifications and cancer 6
- PI3K/AKT/mTOR signaling in cancer 2
- Ubiquitin and proteasome pathways 2
- Geophysics top 10%
-
- Peptidase Inhibition and Analysis 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
-
- Plant Water Relations and Carbon Dynamics 2
-
- Gastric Cancer Management and Outcomes 2
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Haibin Liang
28 papers receiving 683 citations
Peers
Comparison fields: 5 of 97
- Cancer Research 193
- Toxicology 27
- Molecular Biology 396
- Geophysics 75
- Oncology 120
Countries citing papers authored by Haibin Liang
This map shows the geographic impact of Haibin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibin Liang more than expected).
Fields of papers citing papers by Haibin Liang
This network shows the impact of papers produced by Haibin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibin Liang. The network helps show where Haibin Liang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haibin Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 23 | |
| 9 | 2021 | 18 | |
| 10 | 2019 | 19 | |
| 11 | 2018 | 23 | |
| 12 | 2018 | 50 | |
| 13 | 2017 | 56 | |
| 14 | 2017 | 64 | |
| 15 | 2017 | 72 | |
| 16 | 2016 | 28 | |
| 17 | 2016 | 43 | |
| 18 | 2016 | 12 | |
| 19 | 2015 | 1 | |
| 20 | 2005 | 18 |
About Haibin Liang
Haibin Liang is a scholar working on Cancer Research, Gastroenterology and Toxicology, having authored 28 papers that have together received 692 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers), Plant Water Relations and Carbon Dynamics (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Peptidase Inhibition and Analysis (2 papers), Ubiquitin and proteasome pathways (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Cancer Research (193 citations), Toxicology (27 citations) and Molecular Biology (396 citations). Haibin Liang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yingbin Liu, Huaifeng Li, Yunping Hu, Shanshan Xiang, Yijian Zhang, Qiang Ma, Fei Zhang, Maolan Li, Zheng Wang and Yuanyuan Ye. Their work appears in journals such as Oncogene, Scientific Reports and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.